Clinical Trials Directory

Trials / Completed

CompletedNCT01998464

Optical Coherence Tomography (OCT) in Retinal Vasculitis

Evaluation of the Utility of OCT Angiography in Assessing Vascular Perfusion in Retinal Vasculitis

Status
Completed
Phase
Study type
Observational
Enrollment
12 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Retinal vasculitis is a sight-threatening inflammation that involves the blood vessels of the retina, the tissue that lines the inside of the eye. This inflammation may occur on its own or as a result of an infectious, cancerous, or inflammatory disorder. Optical coherence tomography (OCT) is an imaging technology that can perform non-contact cross-sectional imaging of retinal and choroidal tissue structure in real time. It is similar to ultrasound imaging, except that OCT measures the intensity of reflected light rather than sound waves. The purpose of this study is to see if non-invasive OCT technology can diagnose retinal vasculitis as well as the more invasive fluorescein angiography, which requires an injection of dye into the vein of an arm of a patient. The study will also compare the mapping of blood vessels (angiography) and loss of blood flow (ischemia) by fluorescein angiography and OCT.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2018-08-23
Completion
2018-08-23
First posted
2013-11-29
Last updated
2024-02-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01998464. Inclusion in this directory is not an endorsement.